Investigations of remibrutinib in models pertinent to multiple sclerosis. Jain RW, Rayatpour A, Hagen K, Morch MT, Randhawa G, Mobarakabadi M, Zhang X, Li C, Nakhaei-Nejad M, Giuliani F, et al. Neurotherapeutics. 2026 May 14; 23(3):e00923. PMID: 42134274. Abstract CommentRecommendBookmarkWatch